Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Synlogic Inc SYBX

Healthcare Biotechnology
Synlogic, Inc. is a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases. The Company is focused on rare metabolic disorders, with its lead program, labafenogene marselecobac (SYNB1934), studied in Synpheny-3, a global, pivotal Phase 3 study for patients with phenylketonuria (PKU), and SYNB1353, a potential treatment for homocystinuria (HCU). The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SYBX)

Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 19, 2024

Synlogic Adopts Limited Duration Stockholders Rights Plan

GlobeNewswire February 20, 2024

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update

GlobeNewswire February 8, 2024

Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria

GlobeNewswire February 2, 2024

Synlogic Provides Corporate Update and Outlook for 2024

GlobeNewswire January 4, 2024

Synlogic Announces Contract with the Air Force Research Lab

GlobeNewswire December 27, 2023

Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023

GlobeNewswire December 7, 2023

Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire November 9, 2023

Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration

GlobeNewswire November 7, 2023
View More News ››

Opinion & Analysis (NDAQ:SYBX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SYBX)

Rare Disease Focused-Synlogic Pulls Plug On Lead Program, Sh

BREAKING NEWS: $SYBX Rare Disease Focused-Synlogic Pulls Plug On Lead Program, Shares Nosedive | BenzingaThursday,@Synlogic Inc@(NASDAQ...
whytestocks - February 9, 2024
View more Bullboard ››

Eastern Platinum Ltd.

Eastern Platinum Ltd.

Eastern Platinum Limited owns directly and indirectly a number of platinum group metals (PGM) and chrome assets in the ...
View More »